Longduoduo Co Ltd
Data quality: 100%
LDDD
OTC
Services
Health Services
$0.93
▲
$0.42
(83.14%)
Mkt Cap: 28.03 M
Price
$0.93
Mkt Cap
28.03 M
Day Range
$0.93 — $0.93
52-Week Range
$0.51 — $5.00
Volume
374
Open $0.93
50D / 200D Avg
$0.54
72.96% above
50D / 200D Avg
$1.85
49.46% below
Quick Summary
Key Takeaways
Earnings declined -63.33% over the past year
Negative free cash flow of -141,625.0
Capital efficient — spends only 1.22% of revenue on capex
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)-63.33%
FCF Growth (3Y)-49.21%
Quality
Return on Equity
-29.73%
Below sector avg (-15.74%)
ROIC-25.20%
Net Margin-10.85%
Op. Margin-12.91%
Safety
Debt / Equity
N/A
Current Ratio1.57
Interest CoverageN/A
Valuation
PE (TTM)
-94.90
Below sector avg (-1.17)
P/B Ratio31.84
EV/EBITDAN/A
Dividend YieldN/A
Price History
Financial Trends
Peer Comparison
vs Services sector median (502 peers)
Peer Comparison
vs Services sector median (502 peers)| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -94.9 | -1.2 |
| P/B | 31.8 | 1.4 |
| ROE % | -29.7 | -15.7 |
| Net Margin % | -10.9 | -18.3 |
| Rev Growth 5Y % | — | 4.2 |
| D/E | — | 0.4 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | 5.66% |
| Earnings Growth (1Y) | -63.33% | Earnings Growth (3Y) | 367.30% |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 2.72 M | Net Income (TTM) | -295,408.0 |
| ROE | -29.73% | ROA | -14.76% |
| Gross Margin | 98.46% | Operating Margin | -12.91% |
| Net Margin | -10.85% | Free Cash Flow (TTM) | -141,625.0 |
| ROIC | -25.20% | FCF Growth (3Y) | -49.21% |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 1.57 |
| Interest Coverage | N/A | Asset Turnover | 1.36 |
| Working Capital | 634,590 | Tangible Book Value | 880,361 |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -94.90 | Forward P/E | N/A |
| P/B Ratio | 31.84 | P/S Ratio | 10.30 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -0.51% | ||
| Market Cap | 28.03 M | Enterprise Value | 28.03 M |
| Per Share | |||
| EPS (Diluted TTM) | -0.01 | Revenue / Share | 0.09 |
| FCF / Share | 0.00 | OCF / Share | 0.00 |
| EPS CAGR (1Y) | -64.29% | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | 1.22% | FCF Conversion | 47.94% |
| SBC-Adj. FCF | N/A | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | 4.26 M | — | 3.82 M | 3.24 M |
| Net Income | 460,435.0 | 1.26 M | 21,085.0 | -7.56 M |
| EPS (Diluted) | 0.02 | 0.04 | 0.00 | -0.03 |
| Gross Profit | 4.17 M | 7.22 M | 3.23 M | 2.23 M |
| Operating Income | 552,679.0 | 2.03 M | 29,238.0 | -7.56 M |
| EBITDA | — | — | — | — |
| R&D Expenses | — | — | — | — |
| SG&A Expenses | 3.62 M | 5.19 M | 3.20 M | 9.79 M |
| D&A | — | — | — | — |
| Interest Expense | — | — | — | — |
| Income Tax | 222,268.0 | 523,207.0 | 10,246.0 | 1,576.0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Total Assets | 2.13 M | 2.06 M | 1.48 M | 610,667.0 |
| Total Liabilities | 830,464.0 | 1.28 M | 2.05 M | 1.63 M |
| Shareholders' Equity | 1.18 M | 702,515.0 | -541,957.0 | -928,786.0 |
| Total Debt | — | — | — | — |
| Cash & Equivalents | — | 1.40 M | 1.14 M | 356,672.0 |
| Current Assets | 1.81 M | 1.66 M | 1.31 M | 424,328.0 |
| Current Liabilities | 830,464.0 | 1.26 M | 2.05 M | 1.63 M |
{"event":"ticker_viewed","properties":{"ticker":"LDDD","listing_kind":"stock","pathname":"/stocks/lddd","exchange":"OTC","country":"US"}}